Changeflow GovPing Pharma & Drug Safety Crohn's Disease Exclusive Enteral Nutrition Cli...
Routine Notice Added Final

Crohn's Disease Exclusive Enteral Nutrition Clinical Trial

Favicon for clinicaltrials.gov ClinicalTrials.gov
Detected April 1st, 2026
Email

Summary

The National Library of Medicine registered a new clinical trial (NCT07504510) on ClinicalTrials.gov evaluating exclusive enteral nutrition therapy for Crohn's disease. The trial focuses on dietary intervention as a treatment modality for inflammatory bowel disease.

What changed

ClinicalTrials.gov recorded a new trial registration for a study investigating exclusive enteral nutrition (EEN) as a therapeutic approach for Crohn's disease. The trial, identified as NCT07504510, will examine the efficacy of nutrition-based therapy in managing inflammatory bowel disease symptoms.

Clinical trial sponsors and investigators should ensure ongoing compliance with ClinicalTrials.gov registration requirements under FDAAA 801. Trial registration must be maintained with current status updates. No immediate action is required for entities not involved in this specific trial.

Source document (simplified)

Show glossary

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
NLM
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
NCT07504510

Who this affects

Applies to
Clinical investigators Healthcare providers Patients
Industry sector
6211 Healthcare Providers
Activity scope
Clinical Trial Registration
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Pharmaceuticals

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ClinicalTrials.gov publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.